Logo-ipp

Immunopathol Persa. 2020;6(1): e02. doi: 10.15171/ipp.2020.02

Original Article

Factors associated with delayed diagnosis of breast cancer; a study in North-West of Iran

Nasrin Fouladi 1 ORCID, Maedeh Barahman 2 ORCID, Firouz Amani 1 * ORCID, Mohammad Bahadoram 2,3 ORCID, Sevda Eghbali 4 ORCID

Cited by CrossRef: 9

1- Nooripour R, Hosseinian S, Ghanbari N, Haghighat S, Matacotta J, Gasparri M. Validation of the Persian version of the satisfaction with life scale (SWLS) in Iranian women with breast Cancer. Curr Psychol. 2023;42(4):2993 [Crossref]
2- Momenimovahed Z, Momenimovahed S, Allahqoli L, Salehiniya H. Factors Related to the Delay in Diagnosis of Breast Cancer in the Word: A Systematic Review. Indian J Gynecol Oncolog. 2022;20(3) [Crossref]
3- Petrova D, Garrido D, Špacírová Z, Fernández‐Martínez N, Ivanova G, Rodríguez‐Barranco M, Pollán M, Barrios‐Rodríguez R, Sánchez M. Duration of the patient interval in breast cancer and factors associated with longer delays in low‐and middle‐income countries: A systematic review with meta‐analysis. Psycho-Oncology. 2023;32(1):13 [Crossref]
4- Sayad S, Ahmadi S, Moradi M, Nekouian R, Anbari K, Shahsavar F. A meta-analysis on diagnostic accuracy of serum HLA-G level in breast cancer. Expert Review of Precision Medicine and Drug Development. 2020;5(2):109 [Crossref]
5- Erami E, Taghadosi M. Factors Contributing to Grief Experience Among Oncology Nurses: A Qualitative Study. Seminars in Oncology Nursing. 2023;39(5):151472 [Crossref]
6- Bao S, Darvishi M, H Amin A, Al-Haideri M, Patra I, Kashikova K, Ahmad I, Alsaikhan F, Al-qaim Z, Al-Gazally M, Kiasari B, Tavakoli-Far B, Sidikov A, Mustafa Y, Akhavan-Sigari R. CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment. J Cancer Res Clin Oncol. 2023;149(10):7945 [Crossref]
7- Ranapour S, Motamed N. Effect of Silibinin on the Expression of Mir-20b, Bcl2L11, and Erbb2 in Breast Cancer Cell Lines. Mol Biotechnol. 2023;65(12):1979 [Crossref]
8- Yang M, Zhang Y, Li M, Liu X, Darvishi M. The various role of microRNAs in breast cancer angiogenesis, with a special focus on novel miRNA-based delivery strategies. Cancer Cell Int. 2023;23(1) [Crossref]
9- Ghasemi Darestani N, Gilmanova A, Al-Gazally M, Zekiy A, Ansari M, Zabibah R, Jawad M, Al-Shalah S, Rizaev J, Alnassar Y, Mohammed N, Mustafa Y, Darvishi M, Akhavan-Sigari R. Mesenchymal stem cell-released oncolytic virus: an innovative strategy for cancer treatment. Cell Commun Signal. 2023;21(1) [Crossref]